HUMACYTE INC shareholders Q2 2023

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 75 filers reported holding HUMACYTE INC in Q2 2023. The put-call ratio across all filers is 45.88 and the average weighting 0.0%.

HUMACYTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
AMALGAMATED BANK 8,597$250.00%
ProShare Advisors LLC 14,650$41,8990.00%
BlackRock Inc. 4,304,505$12,310,8850.00%
Bank of New York Mellon Corp 261,106$746,7640.00%
Nuveen Asset Management, LLC 81,778$233,8850.00%
Citadel Advisors 36,700$104,9620.00%
Citadel Advisors 39,089$111,7940.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 54,268$155,2060.00%
Daiwa Securities Group Inc. 301$10.00%
SIMPLEX TRADING, LLC 3,974$110.00%
Citadel Advisors 800$2,2880.00%
Allspring Global Investments Holdings, LLC 26,665$76,2610.00%
JPMORGAN CHASE & CO 53,526$153,0850.00%
Renaissance Technologies 71,600$2050.00%
BARCLAYS PLC 70,843$2030.00%
ROYAL BANK OF CANADA 4,485$13,0000.00%
Allworth Financial LP 200$5720.00%
VANGUARD GROUP INC 2,968,636$8,490,2990.00%
JANE STREET GROUP, LLC 27,202$77,7980.00%
Avior Wealth Management, LLC 1,000$2,8600.00%

This page lists HUMACYTE INC's shareholders in Q2 2023. To view HUMACYTE INC's shareholder history, click here.